Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)
15.66
+0.15 (0.97%)
Jul 29, 2026, 3:00 PM CST
SHA:600129 Revenue
Chongqing Taiji Industry(Group) Co.,Ltd had revenue of 2.53B CNY in the quarter ending March 31, 2026, a decrease of -10.59%. This brings the company's revenue in the last twelve months to 10.20B, down -7.32% year-over-year. In the year 2025, Chongqing Taiji Industry(Group) Co.,Ltd had annual revenue of 10.50B, down -15.23%.
Revenue (ttm)
10.20B
Revenue Growth
-7.32%
P/S Ratio
0.85
Revenue / Employee
938.92K
Employees
10,864
Market Cap
8.64B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.50B | -1.89B | -15.23% |
| Dec 31, 2024 | 12.39B | -3.24B | -20.72% |
| Dec 31, 2023 | 15.62B | 1.50B | 10.58% |
| Dec 31, 2022 | 14.13B | 1.98B | 16.28% |
| Dec 31, 2021 | 12.15B | 941.63M | 8.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| North China Pharmaceutical Company.Ltd | 8.82B |
| Zhejiang Xianju Pharmaceutical | 3.67B |
| Porton Pharma Solutions | 3.50B |
| Beijing Foyou Pharma CO.,LTD | 3.49B |
| Sunflower Pharmaceutical Group | 2.50B |
| Jiuzhitang | 2.40B |
| Guilin Sanjin Pharmaceutical | 2.10B |
| PharmaBlock Sciences (Nanjing) | 2.03B |